Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5913414 | Blood Cells, Molecules, and Diseases | 2016 | 28 Pages |
Abstract
We conclude that the addition of CD135 and CD117 to the diagnosis can predict molecular aberrations in T-ALL settings, mainly segregating patients with FLT3-ITD, who would benefit from treatment with inhibitors of tyrosine.
Keywords
CD117EGILB-cell precursor ALLAMLTKDFLT3 mutationsBCP-ALLPerCPBFMMoAbITDMUTAPCWBCFITCMFITCrSSCallophycocyaninMonoclonal antibodyT-ALLinternal tandem duplicationMultiparametric flow cytometrymutatedPeripheral bloodTyrosine kinase domainmedian fluorescence intensityWhite blood cell countphycoerythrinacute myeloid leukemiaT-cell acute lymphoblastic leukemiaAcute lymphoblastic leukemiapositive bone marrownegativewild typenegALLside scatterposT-cell receptor
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Biology
Authors
Elda Pereira Noronha, Francianne Gomes Andrade, Carolina Zampier, Camilla F.C.G. de Andrade, Eugênia Terra-Granado, Maria S. Pombo-de-Oliveira,